Rare aggressive fungal infection strikes healthy patient after trauma

In a striking reminder that “flesh-eating” infections are not always bacterial, clinicians in Chongqing, China have documented a near-fatal case of fulminant mucormycosis — a devastating fungal infection — in a completely healthy 55-year-old man who developed the disease after a crushing injury to his lower leg. The case, published as an open-access case report in BMC Infectious Diseases, describes how an otherwise unremarkable industrial trauma spiraled within days into septic shock, widespread tissue death, and ultimately the loss of the patient’s leg, despite rapid diagnosis and aggressive, guideline-directed therapy.

The report matters because mucormycosis is widely regarded as a disease of the profoundly immunocompromised — patients with poorly controlled diabetes, hematologic malignancies, neutropenia, or those on powerful immunosuppressive drugs. In those settings, fungi of the order Mucorales, including Rhizopus, Mucor, and Lichtheimia species, can invade blood vessels and cause rapidly progressive necrosis. But infections like this in a healthy host are rare enough that emergency physicians and trauma surgeons may not think of them until it is too late. The Chinese team, led by corresponding authors Dawei Zhang and Yang Li, with first authors Qiu Zhong and Qimi Yuan, argues that this case should reset that assumption.

The patient’s ordeal began with a severe crush injury to the right lower leg — the kind of high-energy trauma that carries a well-known risk of bacterial necrotizing soft tissue infection. Initially, the clinical picture and standard management proceeded along conventional lines. But the wound deteriorated in a way that should raise alarm in any clinician: pain that was far out of proportion to the visible injury, spreading black eschar (dead tissue forming a leathery crust), and evidence of vascular thrombosis — clotting of the blood vessels supplying the skin and muscle. The patient then developed septic shock, the life-threatening collapse of blood pressure and organ perfusion that marks the most severe end of the infection spectrum.

The critical diagnostic turning point came from the microscope. When tissue obtained during surgical debridement was examined directly, the laboratory team saw broad, ribbon-like fungal hyphae with very few septa — the cross-walls characteristic of many other filamentous fungi. This pauciseptate, ribbon-like morphology is the classic microscopic signature of the Mucorales, and it distinguishes them from the thinner, more heavily septate hyphae of Aspergillus. In the context of necrotizing soft tissue infection, that single observation converts a diffuse diagnostic problem into a specific emergency: angioinvasive mucormycosis, a condition in which fungal hyphae invade and occlude arteries and veins, cutting off blood supply and accelerating tissue death.

Confirmation required more. Culture of the debrided tissue grew the organism, and whole-genome sequencing (WGS) identified it precisely as Mucor circinelloides — a species that is an infrequent cause of fulminant disease in immunocompetent people compared with other members of the Mucorales. The use of WGS is notable in itself: precise species-level identification matters clinically, because different Mucorales species vary in their susceptibility profiles and in how reliably they respond to available antifungal drugs. Traditional culture alone can be slow and sometimes fails entirely, while molecular methods such as whole-genome sequencing and metagenomic next-generation sequencing (mNGS) are increasingly deployed in severe, rapidly progressing cases where every hour counts.

Treatment followed the standard two-pronged approach for invasive mucormycosis: antifungal chemotherapy and surgery. The patient received liposomal amphotericin B, the polyene antifungal that remains the backbone of first-line therapy for Mucorales infections, at a standard dose. Repeated surgical debridement removed necrotic tissue in an attempt to stay ahead of the advancing fungal front. Yet the combination was not enough to save the limb. The infection progressed despite these measures, and the surgical team performed a transtibial amputation — removal of the leg below the knee — as a life-saving measure. Once the fungal reservoir was surgically removed, the patient recovered.

That outcome, grim as it sounds, actually represents a relative success. Fulminant post-traumatic mucormycosis carries high mortality, and survival frequently depends on the triad the authors emphasize: urgent microscopy of debrided tissue, aggressive surgical debridement, and prompt antifungal therapy. Every delay — in recognizing the fungal etiology, in starting amphotericin B, or in returning to the operating room — translates directly into more advancing necrosis and a higher risk of death. In this case, the decisive combination of early microscopy and rapid escalation to amputation, together with antifungal therapy, is what saved the patient’s life even though the limb could not be preserved.

The biology underlying the infection helps explain why it behaves so violently. Mucorales fungi are angioinvasive: their hyphae physically invade the walls of arteries and veins, provoking thrombosis that starves tissue of oxygen while simultaneously creating vast necrotic zones in which the fungus itself thrives, because these organisms preferentially grow in high-glucose, acidic, poorly perfused environments. Necrotic tissue is also poorly penetrated by antifungal drugs, which is why debridement is not adjunctive but essential — amphotericin B cannot cure tissue that it cannot reach. Trauma introduces fungal spores, ubiquitous in soil and decaying organic matter, directly into deep tissue, bypassing normal skin barriers and seeding infection in a wound bed compromised by crushed muscle, disrupted vasculature, and hematoma.

The authors’ central message to clinicians is a simple but potentially life-saving heuristic: when tissue necrosis is disproportionate to the apparent injury, angioinvasive fungi must be considered regardless of the patient’s immune status. Disproportionate pain out of keeping with wound appearance, rapidly extending black eschar, gas or vascular thrombosis on imaging, and failure to improve despite appropriate antibacterial therapy should all trigger urgent consideration of mucormycosis. The single fastest test available — direct microscopy of tissue for broad, pauciseptate, ribbon-like hyphae — can be performed within hours and should be requested early when these red flags appear, rather than waiting days for culture results that may never come.

The case also adds to a small but growing literature suggesting that Mucor circinelloides, long considered a less virulent member of the Mucorales, is capable of causing devastating, life-threatening disease in people with no identifiable immune defect. For researchers, the report underscores the value of modern diagnostic pipelines — culture coupled with whole-genome sequencing — in pinpointing rare pathogens and building a better picture of which fungal species are capable of fulminant post-traumatic infection. For frontline clinicians, it is a stark case study: crush injuries that look superficially manageable can harbor an opportunist that is neither a bacterium nor a patient of the usual risk profile, and the only defense is a high index of suspicion, a fast microscope, a fast scalpel, and fast amphotericin.

The patient, who provided written informed consent for publication of the report, survived and recovered following the amputation. The report was supported in part by the New Chongqing Youth Innovation Talent Project and an Army Medical University innovation program. The authors declare no competing interests, and the article is published under a Creative Commons license, making the full clinical details freely available to clinicians worldwide who may one day face the same scenario in their own trauma bay.